Sebelipase alfa for treating Wolman disease

Equality Impact Assessment (Guidance development) (PDF 138 KB)

Final evaluation determination

Final draft guidance (PDF 280 KB)

Committee papers (PDF 1.34 MB)

Public committee slides (PDF 995 KB)

Evaluation consultation

Draft guidance (PDF version) (PDF 306 KB)

Committee papers (PDF 8.2 MB)

Public committee slides (PowerPoint 1.89 MB)

Draft guidance (PDF version) Equality Impact Assessment  (PDF 143 KB)

Draft guidance (online commenting)

Committee meeting: 2

Supporting documentation Register of Interests (PDF 172 KB)

Final scope (PDF 228 KB)

Final stakeholder list (PDF 167 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 343 KB)

Equality impact assessment (Scoping) (PDF 127 KB)

Draft scope post referral (PDF 237 KB)

Draft matrix post referral (PDF 166 KB)